NPH insulin

NPH insulin is a medium-acting insulin. NPH

insulin has a long duration of action and provides relatively stable glycemic control. It takes effect gradually over a period of time after injection, with a relatively slow peak of action and effective control of basal blood glucose levels.

It is often used in diabetic patients who need basal insulin supplement, especially type 1 diabetic patients or type 2 diabetic patients who are poorly controlled by oral hypoglycemic drugs. It is

generally administered by subcutaneous injection. The injection site can be selected from abdomen, thigh, buttocks, etc. It is necessary to pay attention to correct injection techniques and rotation of injection sites to reduce the occurrence of local adverse reactions.

During NPH insulin use, patients need to closely monitor blood glucose and adjust the dose according to changes in blood glucose to achieve individualized glycemic control goals.

Sometimes it may be necessary to combine it with short-acting insulin or other antidiabetic drugs to better control blood glucose fluctuations throughout the day.

Adverse reactions such as hypoglycemia and injection site reactions may occur. Patients and healthcare professionals need to understand these potential risks and take appropriate measures to prevent and manage them.